44 results on '"Ishida, Hidekazu"'
Search Results
2. Trans-subclavian approach for Impella CP implantation using the chimney graft in a pediatric patient with fulminant myocarditis during extracorporeal support
- Author
-
Hirose, Masaki, Ishida, Hidekazu, Kawamura, Takuji, Narita, Jun, Ishii, Ryo, Watanabe, Takuji, Taira, Masaki, Ueno, Takayoshi, Ozono, Keiichi, and Miyagawa, Shigeru
- Published
- 2023
- Full Text
- View/download PDF
3. Reliability of transient elastography as a noninvasive method for estimating central venous pressure in adult patients after a Fontan procedure
- Author
-
Emi, Misugi, Sera, Fusako, Tsukamoto, Yasumasa, Akazawa, Yasuhiro, Nakamoto, Kei, Ishii, Ryo, Ishida, Hidekazu, Narita, Jun, Taira, Masaki, Ohtani, Tomohito, Hikoso, Shungo, Miyagawa, Shigeru, and Sakata, Yasushi
- Published
- 2023
- Full Text
- View/download PDF
4. Pediatric patient with restrictive cardiomyopathy on staged biventricular assist device support with Berlin Heart EXCOR® underwent heart transplantation successfully: the first case in Japan
- Author
-
Araki, Kanta, Ueno, Takayoshi, Taira, Masaki, Kanaya, Tomomitsu, Watanabe, Takuji, Tominaga, Yuji, Ishii, Ryo, Ishida, Hidekazu, Narita, Jun, Toda, Koichi, Kuratani, Toru, and Sawa, Yoshiki
- Published
- 2021
- Full Text
- View/download PDF
5. Innovative therapeutic strategy using prostaglandin I2 agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
- Author
-
Kanaya, Tomomitsu, Miyagawa, Shigeru, Kawamura, Takuji, Sakai, Yoshiki, Masada, Kenta, Nawa, Nobutoshi, Ishida, Hidekazu, Narita, Jun, Toda, Koichi, Kuratani, Toru, and Sawa, Yoshiki
- Published
- 2021
- Full Text
- View/download PDF
6. Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
- Author
-
Hasegawa, Moyu, Miki, Kenji, Kawamura, Takuji, Takei Sasozaki, Ikue, Higashiyama, Yuki, Tsuchida, Masaru, Kashino, Kunio, Taira, Masaki, Ito, Emiko, Takeda, Maki, Ishida, Hidekazu, Higo, Shuichiro, Sakata, Yasushi, and Miyagawa, Shigeru
- Subjects
HEART ,GENETIC overexpression ,INDUCED pluripotent stem cells ,CARDIOMYOPATHIES - Abstract
Research on cardiomyopathy models using engineered heart tissue (EHT) created from disease‐specific induced pluripotent stem cells (iPSCs) is advancing rapidly. However, the study of restrictive cardiomyopathy (RCM), a rare and intractable cardiomyopathy, remains at the experimental stage because there is currently no established method to replicate the hallmark phenotype of RCM, particularly diastolic dysfunction, in vitro. In this study, we generated iPSCs from a patient with early childhood‐onset RCM harboring the TNNI3 R170W mutation (R170W‐iPSCs). The properties of R170W‐iPSC‐derived cardiomyocytes (CMs) and EHTs were evaluated and compared with an isogenic iPSC line in which the mutation was corrected. Our results indicated altered calcium kinetics in R170W‐iPSC‐CMs, including prolonged tau, and an increased ratio of relaxation force to contractile force in R170W‐EHTs. These properties were reversed in the isogenic line, suggesting that our model recapitulates impaired relaxation of RCM, i.e., diastolic dysfunction in clinical practice. Furthermore, overexpression of wild‐type TNNI3 in R170W‐iPSC‐CMs and ‐EHTs effectively rescued impaired relaxation. These results highlight the potential efficacy of EHT, a modality that can accurately recapitulate diastolic dysfunction in vitro, to elucidate the pathophysiology of RCM, as well as the possible benefits of gene therapies for patients with RCM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Isogenic pairs of induced-pluripotent stem-derived endothelial cells identify DYRK1A/PPARG/EGR1 pathway is responsible for Down syndrome-associated pulmonary hypertension.
- Author
-
Suginobe, Hidehiro, Ishida, Hidekazu, Ishii, Yoichiro, Ueda, Kazutoshi, Yoshihara, Chika, Ueyama, Atsuko, Wang, Renjie, Tsuru, Hirofumi, Hashimoto, Kazuhisa, Hirose, Masaki, Ishii, Ryo, Narita, Jun, Kitabatake, Yasuji, and Ozono, Keiichi
- Published
- 2024
- Full Text
- View/download PDF
8. Analysis of public concerns about influenza vaccinations by mining a massive online question dataset in Japan
- Author
-
Nawa, Nobutoshi, Kogaki, Shigetoyo, Takahashi, Kunihiko, Ishida, Hidekazu, Baden, Hiroki, Katsuragi, Shinichi, Narita, Jun, Tanaka-Taya, Keiko, and Ozono, Keiichi
- Published
- 2016
- Full Text
- View/download PDF
9. Endocardium differentiation through Sox17 expression in endocardium precursor cells regulates heart development in mice
- Author
-
Saba, Rie, Kitajima, Keiko, Rainbow, Lucille, Engert, Silvia, Uemura, Mami, Ishida, Hidekazu, Kokkinopoulos, Ioannis, Shintani, Yasunori, Miyagawa, Shigeru, Kanai, Yoshiakira, Kanai-Azuma, Masami, Koopman, Peter, Meno, Chikara, Kenny, John, Lickert, Heiko, Saga, Yumiko, Suzuki, Ken, Sawa, Yoshiki, and Yashiro, Kenta
- Published
- 2019
- Full Text
- View/download PDF
10. Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects.
- Author
-
Ishida, Hidekazu, Maeda, Jun, Uchida, Keiko, and Yamagishi, Hiroyuki
- Published
- 2023
- Full Text
- View/download PDF
11. Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy.
- Author
-
Tominaga, Yuji, Taira, Masaki, Watanabe, Takuji, Kugo, Yosuke, Hasegawa, Moyu, Narita, Jun, Ishida, Hidekazu, Sakaniwa, Ryoto, Ueno, Takayoshi, and Miyagawa, Shigeru
- Subjects
DNA repair ,DNA ,DILATED cardiomyopathy ,CHILD patients ,PROPORTIONAL hazards models - Abstract
Open in new tab Download slide OBJECTIVES The goal of this study was to identify the clinical significance of the deoxyribonucleic acid (DNA) damage response marker, phosphorylated H2A histone variant X, on the bridge to recovery in low-weight paediatric patients with dilated cardiomyopathy (DCM) after having a Berlin Heart EXCOR implanted. METHODS Consecutive paediatric patients with DCM who had an EXCOR implanted for DCM at our hospital between 2013 and 2021 were reviewed. Patients were classified into 2 groups according to the degree of DNA damage in the left ventricular cardiomyocytes—the low DNA damage group and the high DNA damage group—using the median value as the threshold. We examined and compared the preoperative factors and histologic findings associated with cardiac functional recovery following the explant procedure in the 2 groups. RESULTS Competing outcome analysis of 18 patients (median body weight, 6.1 kg) showed that the incidence of an EXCOR explant was 40% at 1 year after the implant procedure. Serial echocardiography revealed significant left ventricular functional recovery in the low DNA damage group 3 months after the implant. The univariable Cox proportional hazards model revealed that the percentage of phosphorylated H2A histone variant X-positive cardiomyocytes was the significant factor associated with cardiac recovery and the EXCOR explant (hazard ratio, 0.16; 95% confidence interval, 0.027–0.51; P = 0.0096). CONCLUSIONS The degree of DNA damage response to the EXCOR implant may aid in predicting the bridge to recovery with EXCOR among low-weight paediatric patients with DCM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Alternatively activated macrophages determine repair of the infarcted adult murine heart
- Author
-
Shiraishi, Manabu, Shintani, Yasunori, Shintani, Yusuke, Ishida, Hidekazu, Saba, Rie, Yamaguchi, Atsushi, Adachi, Hideo, Yashiro, Kenta, and Suzuki, Ken
- Subjects
Heart attack -- Care and treatment ,Biological products -- Innovations ,Phosphotransferases -- Health aspects ,Macrophages -- Genetic aspects ,Health care industry - Abstract
Alternatively activated (also known as M2) macrophages are involved in the repair of various types of organs. However, the contribution of M2 macrophages to cardiac repair after myocardial infarction (MI) remains to be fully characterized. Here, we identified [CD206.sup.+]F4/[80.sup.+][CD11b.sup.+] M2-like macrophages in the murine heart and demonstrated that this cell population predominantly increases in the infarct area and exhibits strengthened reparative abilities after MI. We evaluated mice lacking the kinase TRIB1 ([Trib1.sup.-/-]), which exhibit a selective depletion of M2 macrophages after MI. Compared with control animals, [Trib1.sup.-/-] mice had a catastrophic prognosis, with frequent cardiac rupture, as the result of markedly reduced collagen fibril formation in the infarct area due to impaired fibroblast activation. The decreased tissue repair observed in [Tribl.sup.-/-] mice was entirely rescued by an external supply of M2-like macrophages. Furthermore, IL-1α and osteopontin were suggested to be mediators of M2-like macrophage-induced fibroblast activation. In addition, IL-4 administration achieved a targeted increase in the number of M2-like macrophages and enhanced the post-MI prognosis of WT mice, corresponding with amplified fibroblast activation and formation of more supportive fibrous tissues in the infarcts. Together, these data demonstrate that M2-like macrophages critically determine the repair of infarcted adult murine heart by regulating fibroblast activation and suggest that IL-4 is a potential biological drug for treating MI., Introduction The formation of connective tissue is an essential process in the healing and repair of almost every tissue and organ, and this process is of particular importance in the [...]
- Published
- 2016
- Full Text
- View/download PDF
13. Atomic force microscopy identifies the alteration of rheological properties of the cardiac fibroblasts in idiopathic restrictive cardiomyopathy.
- Author
-
Matsumoto, Mizuki, Tsuru, Hirofumi, Suginobe, Hidehiro, Narita, Jun, Ishii, Ryo, Hirose, Masaki, Hashimoto, Kazuhisa, Wang, Renjie, Yoshihara, Chika, Ueyama, Atsuko, Tanaka, Ryosuke, Ozono, Keiichi, Okajima, Takaharu, and Ishida, Hidekazu
- Subjects
ATOMIC force microscopy ,RHEOLOGY ,RHEOLOGY (Biology) ,DIASTOLE (Cardiac cycle) ,CELL communication ,GENE expression profiling ,CARDIOMYOPATHIES - Abstract
Restrictive cardiomyopathy (RCM) is a rare disease characterized by increased ventricular stiffness and preserved ventricular contraction. Various sarcomere gene variants are known to cause RCM; however, more than a half of patients do not harbor such pathogenic variants. We recently demonstrated that cardiac fibroblasts (CFs) play important roles in inhibiting the diastolic function of cardiomyocytes via humoral factors and direct cell–cell contact regardless of sarcomere gene mutations. However, the mechanical properties of CFs that are crucial for intercellular communication and the cardiomyocyte microenvironment remain less understood. In this study, we evaluated the rheological properties of CFs derived from pediatric patients with RCM and healthy control CFs via atomic force microscopy. Then, we estimated the cellular modulus scale factor related to the cell stiffness, fluidity, and Newtonian viscosity of single cells based on the single power-law rheology model and analyzed the comprehensive gene expression profiles via RNA-sequencing. RCM-derived CFs showed significantly higher stiffness and viscosity and lower fluidity compared to healthy control CFs. Furthermore, RNA-sequencing revealed that the signaling pathways associated with cytoskeleton elements were affected in RCM CFs; specifically, cytoskeletal actin-associated genes (ACTN1, ACTA2, and PALLD) were highly expressed in RCM CFs, whereas several tubulin genes (TUBB3, TUBB, TUBA1C, and TUBA1B) were down-regulated. These results implies that the signaling pathways associated with cytoskeletal elements alter the rheological properties of RCM CFs, particularly those related to CF–cardiomyocyte interactions, thereby leading to diastolic cardiac dysfunction in RCM. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Validation of the Martin method to estimate low-density lipoprotein cholesterol concentrations in Japanese populations and a modified method for laboratory information system application.
- Author
-
Ishida, Hidekazu, Yamamoto, Yasuko, Saito, Midori, Ishihara, Yuya, Fujita, Takashi, Ishida, Mariko, Kato, Yohei, Nohisa, Yuzuru, Matsunami, Hidetoshi, Takemura, Masao, Hata, Tadayoshi, Ito, Hiroyasu, and Saito, Kuniaki
- Abstract
Objectives: High concentrations of low-density lipoprotein cholesterol (LDL-C) are a risk factor for cardiovascular disease. We validated the efficacy of the Martin method is useful in the estimation of LDL-C concentrations was validated in Japanese populations and derived a modified Martin method for easy laboratory information system applications. Methods: We created 3 subject groups, including 2664 health check-up participants registered with the Resource Center for Health Science, 29,806 clinical patients (A) in the Gifu University Hospital, and 113,716 clinical patients (B) in the Fujita Health University Hospital. Each method to estimate serum LDL-C concentrations (Friedewald formula, Martin method and modified Martin method) was validated by correlation analysis with serum LDL-C concentrations measured using a direct method Results: The correlation coefficients with the direct method in terms of the Friedewald formula, Martin method, and modified Martin method were 0.963, 0.972 and 0.970 in the health check-up participants; 0.946, 0.962 and 0.961 in clinical patients A; and 0.961, 0.979 and 0.978 in clinical patients B, respectively. Concordance ratios with using the direct method in the Friedewald formula, Martin method and modified Martin method were 82.8%, 85.5% and 85.3% in the health check-up participants; 76.4%, 80.5% and 80.2% in clinical patients A; and 76.1%, 82.6% and 82.6% in clinical patients B, respectively. Conclusion: Our results show that the Martin and modified Martin methods display good performance in terms of the estimation of LDL-C concentrations among triglyceride concentrations of a wide range, and they may thus be useful for estimating LDL-C concentrations. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Riociguat in children with pulmonary arterial hypertension: The PATENT–CHILD study.
- Author
-
García Aguilar, Humberto, Gorenflo, Matthias, Ivy, D. Dunbar, Moledina, Shahin, Castaldi, Biagio, Ishida, Hidekazu, Cześniewicz, Paweł, Kusa, Jacek, Miera, Oliver, Pattathu, Joseph, Weng, Ken‐Pen, Ablonczy, Laszlo, Apitz, Christian, Katona, Marta, Kurosaki, Kenichi, Pulido, Tomas, Yamagishi, Hiroyuki, Yasuda, Kazushi, Cisternas, Galia, and Goth, Melanie
- Subjects
PULMONARY arterial hypertension ,CHILD patients ,ENDOTHELIN receptors ,GUANYLATE cyclase - Abstract
Riociguat, a soluble guanylate cyclase stimulator, is approved for treatment of adults with pulmonary arterial hypertension (PAH). The safety, tolerability, and pharmacokinetics (PK) of oral riociguat in a pediatric population with PAH was assessed in PATENT–CHILD (NCT02562235), a multicenter, single‐arm, 24‐week, open‐label, Phase 3 study. Patients aged 6–17 years in World Health Organization functional class (WHO‐FC) I–III treated with stable endothelin receptor antagonists and/or prostacyclin analogs received riociguat equivalent to 0.5–2.5 mg three times daily in adults, as either oral pediatric suspension or tablets, based on bodyweight. Primary outcomes were safety, tolerability, and PK of riociguat. Twenty‐four patients (mean age 12.8 years), 18 of whom were in WHO‐FC II, were enrolled. Adverse events (AEs), mostly mild or moderate, were reported in 20 patients (83%). Four patients (17%) experienced a serious AE; all resolved by study end and two (8%) were considered study‐drug related. Hypotension was reported in three patients and hemoptysis in one (all mild/moderate intensity). Riociguat plasma concentrations in pediatric patients were consistent with those published in adult patients. From baseline to Week 24, mean ± standard deviation increase in 6‐minute walking distance was 23 ± 69 m (n = 19), and mean decrease in NT‐proBNP was –66 ± 585 pg/ml (n = 14). There was no change in WHO‐FC. Two patients experienced clinical worsening events of hospitalization for right heart failure. PK results confirmed a suitable riociguat dosing strategy for pediatric patients with PAH. The data suggest an acceptable safety profile with potential efficacy signals. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy.
- Author
-
Hirose, Masaki, Narita, Jun, Hashimoto, Kazuhisa, Ishii, Ryo, Ishida, Hidekazu, and Ozono, Keiichi
- Subjects
CARDIOVASCULAR surgery ,DRUG delivery systems ,PATIENT aftercare ,HOMOGRAFTS ,TRANSLUMINAL angioplasty ,DRUG-eluting stents ,CARDIOMYOPATHIES ,SURGICAL stents ,CORONARY restenosis ,PEDIATRIC cardiology ,TREATMENT effectiveness ,EVEROLIMUS ,CORONARY artery disease ,IMMUNOSUPPRESSIVE agents ,VASCULAR diseases ,HEART diseases ,TACROLIMUS ,EQUIPMENT & supplies - Abstract
Cardiac allograft vasculopathy (CAV) sometimes leads to restenosis, even after percutaneous transcatheter intervention. Recently, drug-coated balloons (DCBs) have been successfully used to treat coronary artery disease, especially CAVs, in adults. However, no studies have used DCBs in pediatric CAVs. We encountered a patient with CAV who underwent cardiac transplantation for restrictive cardiomyopathy at the age of 2 years. Nine years after the transplantation, severe stenosis of the proximal left anterior descending branch was observed. Considering the patient's young age and the possibility of restenosis, we performed an intervention with DCB. Follow-up conducted 7 months after the intervention showed no restenosis. Cardiac coronary artery lesions following transplantation are more likely to result in restenosis earlier than arteriosclerotic lesions. In pediatric patients, restenosis might require multiple stents and prolonged antiplatelet therapy. Our findings provide evidence supporting the possibility of an effective treatment of CAV in children. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Attenuation of bone morphogenetic protein receptor type 2 expression in the pulmonary arteries of patients with failed Fontan circulation
- Author
-
Ishida, Hidekazu, Kogaki, Shigetoyo, Takahashi, Kunihiko, and Ozono, Keiichi
- Published
- 2012
- Full Text
- View/download PDF
18. Serum GP88 as a predictive biomarker for hepatocellular carcinoma in patients with viral hepatitis C after direct-acting antiviral agents.
- Author
-
Ishida, Hidekazu, Takemura, Masao, Suetsugu, Atsushi, Naiki, Takafumi, Tanaka, Takuji, Eiichi, Tomita, Serrero, Ginette, Matsunami, Hidetoshi, Yamamoto, Yasuko, and Saito, Kuniaki
- Subjects
- *
HEPATOCELLULAR carcinoma , *PROGRANULIN , *NEOPLASTIC cell transformation , *BIOMARKERS , *HEPATITIS C , *ANTIVIRAL agents - Abstract
Background: Progranulin (GP88) is an 88-kDa glycoprotein growth factor with important biological effects in tumorigenesis and tumour survival. We investigated the usefulness of measuring serum GP88 concentrations as a predictive biomarker for hepatocellular carcinoma in patients with viral hepatitis C after treatment with direct-acting antiviral agents. Methods: We measured the serum GP88 concentrations by using a sandwich enzyme-linked immunoassay from 67 healthy control subjects and 29 patients (20 patients who did not develop hepatocellular carcinoma and 9 patients who developed hepatocellular carcinoma after treatment) with viral hepatitis C after treatment with asunaprevir and daclatasvir. Results: The serum GP88 concentrations of patients with chronic hepatitis C prior to antiviral treatment were significantly higher than those of healthy control subjects. After antiviral treatment, the serum GP88 concentrations of patients who eventually developed hepatocellular carcinoma were significantly higher than those who did not develop hepatocellular carcinoma. The changes in the serum GP88 concentrations before and after treatment in patients who developed hepatocellular carcinoma were significantly lower than those in patients who did not develop hepatocellular carcinoma. The cumulative incidence of hepatocellular carcinoma was significantly higher in either patients with high serum GP88 concentrations after treatment or those with small changes of serum GP88 concentrations pre- and post-treatment. Conclusions: Sustained high concentrations of serum GP88 in patients treated with direct-acting antiviral agents are correlated with the risk of developing hepatocellular carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Riociguat can ameliorate bronchopulmonary dysplasia in the SU5416 induced rat experimental model.
- Author
-
Katsuragi, Shinichi, Ishida, Hidekazu, Suginobe, Hidehiro, Tsuru, Hirofumi, Wang, Renjie, Yoshihara, Chika, Ueyama, Atsuko, Narita, Jun, Ishii, Ryo, Kogaki, Shigetoyo, and Ozono, Keiichi
- Subjects
- *
BRONCHOPULMONARY dysplasia , *ANIMAL disease models , *CYCLIC guanylic acid , *NEONATAL diseases , *OVERALL survival , *SURVIVAL rate - Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature neonates. Classical BPD is caused by hyperoxia and high-pressure mechanical ventilation, whereas BPD in recent era is caused by impaired pulmonary angiogenesis and alveolarization in extreme prematurity. Although sildenafil was reported to be effective in a hyperoxia-induced rat BPD model, several clinical trials could not demonstrate any significant improvement in the respiratory statuses of BPD infants. Riociguat is a soluble guanylate cyclase stimulator that increases cyclic guanosine monophosphate activity in a nitric oxide independent manner. However, a beneficial effect in BPD has not been established yet. We established BPD model in rats by injection of SU5416 on day 1 followed by maintenance under normoxia, which resulted in oversimplified alveoli, sparse pulmonary capillary vessels, severe pulmonary hypertension, and growth retardation, which mimicked the features observed in recent clinical management of BPD. We administered riociguat from day 10, when BPD rats exhibited growth retardation. Histological analyses demonstrated that riociguat treatment significantly but partially ameliorated lung alveolarization, vascularization, and pulmonary hypertension. However, the survival rate was not significantly improved by riociguat treatment. Riociguat could ameliorate pulmonary alveolarization, vascularization, and hypertension in the SU5416 induced BPD rat model, but could not improve the overall survival. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. CD8+ T cell activation by murine erythroblasts infected with malaria parasites
- Author
-
Imai, Takashi, Ishida, Hidekazu, Suzue, Kazutomo, Hirai, Makoto, Taniguchi, Tomoyo, Okada, Hiroko, Suzuki, Tomohisa, Shimokawa, Chikako, and Hisaeda, Hajime
- Published
- 2013
- Full Text
- View/download PDF
21. Simple aortic coarctation coincidentally detected by school heart screening in a 7-year-old boy.
- Author
-
Nagano, Hiroki, Ishii, Ryo, Ishida, Hidekazu, Narita, Jun, and Ozono, Keiichi
- Published
- 2022
- Full Text
- View/download PDF
22. GFRA2 Identifies Cardiac Progenitors and Mediates Cardiomyocyte Differentiation in a RET-Independent Signaling Pathway.
- Author
-
Ishida, Hidekazu, Saba, Rie, Kokkinopoulos, Ioannis, Hashimoto, Masakazu, Yamaguchi, Osamu, Nowotschin, Sonja, Shiraishi, Manabu, Ruchaya, Prashant, Miller, Duncan, Harmer, Stephen, Poliandri, Ariel, Kogaki, Shigetoyo, Sakata, Yasushi, Dunkel, Leo, Tinker, Andrew, Hadjantonakis, Anna-Katerina, Sawa, Yoshiki, Sasaki, Hiroshi, Ozono, Keiichi, and Suzuki, Ken
- Published
- 2023
- Full Text
- View/download PDF
23. Reversible cerebral vasoconstriction syndrome after heart transplantation.
- Author
-
Tsukahara, Rie, Ishida, Hidekazu, Narita, Jun, Ishii, Ryo, and Ozono, Keiichi
- Subjects
- *
HEART transplantation , *MAGNETIC resonance angiography , *CEREBRAL vasospasm , *VASOCONSTRICTION , *COMPUTED tomography , *REHABILITATION - Abstract
The article presents a case study of 13-year-old boy with dilated cardiomyopathy underwent heart transplantation at our hospital after continuous inotropic drug infusion. The article discusses that Magnetic resonance angiography clearly showed segmental vasoconstriction of the right posterior and middle cerebral arteries; and Calcium channel blockers were reported to be effective in reducing thunderclap headaches.
- Published
- 2021
- Full Text
- View/download PDF
24. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii.
- Author
-
Imai, Takashi, Suzue, Kazutomo, Ngo-Thanh, Ha, Ono, Suguri, Orita, Wakako, Suzuki, Haruka, Shimokawa, Chikako, Olia, Alex, Obi, Seiji, Taniguchi, Tomoyo, Ishida, Hidekazu, Van Kaer, Luc, Murata, Shigeo, Tanaka, Keiji, and Hisaeda, Hajime
- Subjects
BLOOD lactate ,PLASMODIUM yoelii ,CELLULAR immunity ,ERYTHROCYTES ,T cells - Abstract
Our previous studies of protective immunity and pathology against blood stage malaria parasites have shown that not only CD4
+ T cells, but also CD8+ T cells and macrophages, are important for host defense against blood stage malaria infection. Furthermore, we found that Plasmodium yoelii 17XNL (PyNL) parasitizes erythroblasts, the red blood cell (RBC) precursor cells, which then express MHC class I molecules. In the present study, we analyzed spleen cytokine production. In CD8+ T cell-depleted mice, IL-10 production in early stage infection was increased over two-fold relative to infected control animals and IL-10+ CD3− cells were increased, whereas IFN-γ production in the late stage of infection was decreased. At day 16 after PyNL infection, CD8+ T cells produced more IFN-γ than CD4+ T cells. We evaluated the involvement of the immunoproteasome in induction of immune CD8+ T cells, and the role of Fas in protection against PyNL both of which are downstream of IFN-γ. In cell transfer experiments, at least the single molecules LMP7, LMP2, and PA28 are not essential for CD8+ T cell induction. The Fas mutant LPR mouse was weaker in resistance to PyNL infection than WT mice, and 20% of the animals died. LPR-derived parasitized erythroid cells exhibited less externalization of phosphatidylserine (PS), and phagocytosis by macrophages was impaired. Furthermore, we tried to identify the cause of death in malaria infection. Blood lactate concentration was increased in the CD8+ T cell-depleted PyNL-infected group at day 19 (around peak parasitemia) to similar levels as day 7 after infection with a lethal strain of Py. When we injected mice with lactate at day 4 and 6 of PyNL infection, all mice died at day 8 despite demonstrating low parasitemia, suggesting that hyperlactatemia is one of the causes of death in CD8+ T cell-depleted PyNL-infected mice. We conclude that CD8+ T cells might control cytokine production to some extent and regulate hyperparasitemia and hyperlactatemia in protection against blood stage malaria parasites. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
25. Prognostic factors of premature closure of the ductus arteriosus in utero: a systematic literature review.
- Author
-
Ishida, Hidekazu, Kawazu, Yukiko, Kayatani, Futoshi, and Inamura, Noboru
- Published
- 2017
- Full Text
- View/download PDF
26. GFRA2 Identifies Cardiac Progenitors and Mediates Cardiomyocyte Differentiation in a RET-Independent Signaling Pathway.
- Author
-
Ishida, Hidekazu, Saba, Rie, Kokkinopoulos, Ioannis, Hashimoto, Masakazu, Yamaguchi, Osamu, Nowotschin, Sonja, Shiraishi, Manabu, Ruchaya, Prashant, Miller, Duncan, Harmer, Stephen, Poliandri, Ariel, Kogaki, Shigetoyo, Sakata, Yasushi, Dunkel, Leo, Tinker, Andrew, Hadjantonakis, Anna-Katerina, Sawa, Yoshiki, Sasaki, Hiroshi, Ozono, Keiichi, and Suzuki, Ken
- Abstract
Summary A surface marker that distinctly identifies cardiac progenitors (CPs) is essential for the robust isolation of these cells, circumventing the necessity of genetic modification. Here, we demonstrate that a Glycosylphosphatidylinositol-anchor containing neurotrophic factor receptor, Glial cell line-derived neurotrophic factor receptor alpha 2 ( Gfra2 ), specifically marks CPs. GFRA2 expression facilitates the isolation of CPs by fluorescence activated cell sorting from differentiating mouse and human pluripotent stem cells. Gfra2 mutants reveal an important role for GFRA2 in cardiomyocyte differentiation and development both in vitro and in vivo. Mechanistically, the cardiac GFRA2 signaling pathway is distinct from the canonical pathway dependent on the RET tyrosine kinase and its established ligands. Collectively, our findings establish a platform for investigating the biology of CPs as a foundation for future development of CP transplantation for treating heart failure. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
27. Cardiomyocyte differentiation from mouse embryonic stem cells using a simple and defined protocol.
- Author
-
Kokkinopoulos, Ioannis, Ishida, Hidekazu, Saba, Rie, Coppen, Steven, Suzuki, Ken, and Yashiro, Kenta
- Abstract
Background: Embryonic stem (ES) cells are pluripotent cells with the ability to differentiate to any cell type of the resident organism. In recent years, significant advances have been made in using these cells to obtain large numbers of cardiomyocyte (CM) -like cells for scientific research and clinical application. A vast number of protocols have emerged describing differentiation methods without the use of animal serum or extracts restrictive for use in a human clinical setting. These techniques follow a complicated procedure, which although successful, show a relatively varied yield among cell batches. Results: We have designed a three-step differentiation protocol using defined reagents and a monolayer culture without feeder cells, avoiding embryoid body formation and multiple trypsin treatment, in which beating foci appeared as early as day 6 in in vitro differentiating conditions. Our results show a high yield of CM reaching approximately 60% of the differentiated cells after 13 days in vitro. Conclusions: We provide a fast, simple, reliable and reproducible protocol for inducing murine ES cells toward a CM-like phenotype comparable to available high-yield protocols, without the use of intermediate trypsinization/passage steps. Developmental Dynamics 245:157-165, 2016. © 2015 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
28. Single-Cell Expression Profiling Reveals a Dynamic State of Cardiac Precursor Cells in the Early Mouse Embryo.
- Author
-
Kokkinopoulos, Ioannis, Ishida, Hidekazu, Saba, Rie, Ruchaya, Prashant, Cabrera, Claudia, Struebig, Monika, Barnes, Michael, Terry, Anna, Kaneko, Masahiro, Shintani, Yasunori, Coppen, Steven, Shiratori, Hidetaka, Ameen, Torath, Mein, Charles, Hamada, Hiroshi, Suzuki, Ken, and Yashiro, Kenta
- Subjects
- *
GENE expression , *HEART cells , *MICE embryology , *PROGENITOR cells , *MESODERM - Abstract
In the early vertebrate embryo, cardiac progenitor/precursor cells (CPs) give rise to cardiac structures. Better understanding their biological character is critical to understand the heart development and to apply CPs for the clinical arena. However, our knowledge remains incomplete. With the use of single-cell expression profiling, we have now revealed rapid and dynamic changes in gene expression profiles of the embryonic CPs during the early phase after their segregation from the cardiac mesoderm. Progressively, the nascent mesodermal gene Mesp1 terminated, and Nkx2-5+/Tbx5+ population rapidly replaced the Tbx5low+ population as the expression of the cardiac genes Tbx5 and Nkx2-5 increased. At the Early Headfold stage, Tbx5-expressing CPs gradually showed a unique molecular signature with signs of cardiomyocyte differentiation. Lineage-tracing revealed a developmentally distinct characteristic of this population. They underwent progressive differentiation only towards the cardiomyocyte lineage corresponding to the first heart field rather than being maintained as a progenitor pool. More importantly, Tbx5 likely plays an important role in a transcriptional network to regulate the distinct character of the FHF via a positive feedback loop to activate the robust expression of Tbx5 in CPs. These data expands our knowledge on the behavior of CPs during the early phase of cardiac development, subsequently providing a platform for further study. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
29. IL-23 protection against Plasmodium berghei infection in mice is partially dependent on IL-17 from macrophages.
- Author
-
Ishida, Hidekazu, Imai, Takashi, Suzue, Kazutomo, Hirai, Makoto, Taniguchi, Tomoyo, Yoshimura, Akihiko, Iwakura, Yoichiro, Okada, Hiroko, Suzuki, Tomohisa, Shimokawa, Chikako, and Hisaeda, Hajime
- Abstract
Although IL-12 is believed to contribute to protective immune responses, the role played by IL-23 (a member of the IL-12 family) in malaria is elusive. Here, we show that IL-23 is produced during infection with Plasmodium berghei NK65. Mice deficient in IL-23 (p19 KO) had higher parasitemia and died earlier than wild-type ( WT) controls. Interestingly, p19 KO mice had lower numbers of IL-17-producing splenic cells than their WT counterparts. Furthermore, mice deficient in IL-17 (17 KO) suffered higher parasitemia than the WT controls, indicating that IL-23-mediated protection is dependent on induction of IL-17 during infection. We found that macrophages were responsible for IL-17 production in response to IL-23. We observed a striking reduction in splenic macrophages in the p19 KO and 17 KO mice, both of which became highly susceptible to infection. Thus, IL-17 appears to be crucial for maintenance of splenic macrophages. Adoptive transfer of macrophages into macrophage-depleted mice confirmed that macrophage-derived IL-17 is required for macrophage accumulation and parasite eradication in the recipient mice. We also found that IL-17 induces CCL2/7, which recruit macrophages. Our findings reveal a novel protective mechanism whereby IL-23, IL-17, and macrophages reduce the severity of infection with blood-stage malaria parasites. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
30. A simple and novel method for RNA-seq library preparation of single cell cDNA analysis by hyperactive Tn5 transposase.
- Author
-
Brouilette, Scott, Kuersten, Scott, Mein, Charles, Bozek, Monika, Terry, Anna, Dias, Kerith-Rae, Bhaw-Rosun, Leena, Shintani, Yasunori, Coppen, Steven, Ikebe, Chiho, Sawhney, Vinit, Campbell, Niall, Kaneko, Masahiro, Tano, Nobuko, Ishida, Hidekazu, Suzuki, Ken, and Yashiro, Kenta
- Abstract
Background: Deep sequencing of single cell-derived cDNAs offers novel insights into oncogenesis and embryogenesis. However, traditional library preparation for RNA-seq analysis requires multiple steps with consequent sample loss and stochastic variation at each step significantly affecting output. Thus, a simpler and better protocol is desirable. The recently developed hyperactive Tn5-mediated library preparation, which brings high quality libraries, is likely one of the solutions. Results and Conclusions: Here, we tested the applicability of hyperactive Tn5-mediated library preparation to deep sequencing of single cell cDNA, optimized the protocol, and compared it with the conventional method based on sonication. This new technique does not require any expensive or special equipment, which secures wider availability. A library was constructed from only 100 ng of cDNA, which enables the saving of precious specimens. Only a few steps of robust enzymatic reaction resulted in saved time, enabling more specimens to be prepared at once, and with a more reproducible size distribution among the different specimens. The obtained RNA-seq results were comparable to the conventional method. Thus, this Tn5-mediated preparation is applicable for anyone who aims to carry out deep sequencing for single cell cDNAs. Developmental Dynamics 241:1584-1590, 2012. © 2012 Wiley Periodicals Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
31. Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients
- Author
-
Ishida, Hidekazu, Kogaki, Shigetoyo, Ichimori, Hiroaki, Narita, Jun, Nawa, Nobutoshi, Ueno, Takayoshi, Takahashi, Kunihiko, Kayatani, Futoshi, Kishimoto, Hidehumi, Nakayama, Masahiro, Sawa, Yoshiki, Beghetti, Maurice, and Ozono, Keiichi
- Subjects
- *
ENDOTHELIN receptors , *PULMONARY artery , *HEART diseases , *VASOCONSTRICTORS , *IMMUNOHISTOCHEMISTRY , *AUTOPSY , *HYPERTROPHY - Abstract
Abstract: Background: Endothelin-1 (ET-1), a potent vasoconstrictor, is considered to be implicated in failing Fontan circulation, however the expressions of ET-1 and endothelin receptor type A (ETAR) and type B (ETBR) in the pulmonary arteries of failed Fontan patients were not elucidated. Methods: Immunohistochemistry and quantitative real-time PCR were used to analyse the expression levels of ET-1 and its receptors in the pulmonary arteries of the autopsy lung tissues of the patients who died after the Fontan procedure (n=10). We divided these patients into 3 groups, failed Fontan (n=4), heart failure (n=3) and non-failed Fontan (n=3), and then compared those to the age-matched normal controls (n=4). Results: The intra-acinar pulmonary arteries of failed Fontan patients showed significant medial hypertrophy. Computational optical density analyses of the immunostaining revealed that the expressions of ET-1, ETAR, and ETBR in the intra-acinar pulmonary arteries were significantly increased in the failed Fontan patients (P<0.05 vs. normal controls), however no significant difference was observed between the non-failed Fontan patients and the normal controls. Quantitative real-time PCR analyses confirmed that the mRNA expressions of ET-1, ETAR, and ETBR were significantly increased in the failed Fontan patients (P<0.05 vs. normal controls). Conclusion: The overexpression of ET-1 and its receptors in the pulmonary arteries can cause pulmonary vasoconstriction and vascular remodelling, leading to failed Fontan circulation. This study suggests a histopathological rationale for the potential benefits of endothelin receptor antagonists in patients with failing Fontan circulation. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
32. An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene.
- Author
-
Miura, Kohji, Namba, Noriyuki, Fujiwara, Makoto, Ohata, Yasuhisa, Ishida, Hidekazu, Kitaoka, Taichi, Kubota, Takuo, Hirai, Haruhiko, Higuchi, Chikahisa, Tsumaki, Noriyuki, Yoshikawa, Hideki, Sakai, Norio, Michigami, Toshimi, Ozono, Keiichi, and Hodgson-Zingman, Denice
- Subjects
GENES ,NATRIURETIC peptide receptors ,LIGANDS (Biochemistry) ,GENETIC mutation ,TRANSGENIC mice ,CARTILAGE cells ,PATIENTS - Abstract
We describe a three-generation family with tall stature, scoliosis and macrodactyly of the great toes and a heterozygous p.Val883Met mutation in Npr2, the gene that encodes the CNP receptor NPR2 (natriuretic peptide receptor 2). When expressed in HEK293A cells, the mutant Npr2 cDNA generated intracellular cGMP (cyclic guanosine monophosphate) in the absence of CNP ligand. In the presence of CNP, cGMP production was greater in cells that had been transfected with the mutant Npr2 cDNA compared to wild-type cDNA. Transgenic mice in which the mutant Npr2 was expressed in chondrocytes driven by the promoter and intronic enhancer of the Col11a2 gene exhibited an enhanced production of cGMP in cartilage, leading to a similar phenotype to that observed in the patients. In addition, blood cGMP concentrations were elevated in the patients. These results indicate that p.Val883Met is a constitutive active gain-of-function mutation and elevated levels of cGMP in growth plates lead to the elongation of long bones. Our findings reveal a critical role for NPR2 in skeletal growth in both humans and mice, and may provide a potential target for prevention and treatment of diseases caused by impaired production of cGMP. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
33. LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling.
- Author
-
Ishida, Hidekazu, Kogaki, Shigetoyo, Narita, Jun, Ichimori, Hiroaki, Nawa, Nobutoshi, Okada, Yoko, Takahashi, Kunihiko, and Ozono, Keiichi
- Subjects
- *
CARDIAC hypertrophy , *CELLULAR control mechanisms , *HEART cells , *CELL differentiation , *CELL lines , *GENETIC transcription , *GENETIC mutation - Abstract
LEOPARD syndrome (LS) is an autosomal dominant inherited multisystemic disorder. Most cases involve mutations in the PTPN11 gene, which encodes the protein tyrosine phosphatase Src homology 2-containing protein phosphatase 2 (SHP2). LS frequently causes severe hypertrophic cardiomyopathy (HCM), even from the fetal period. However, the molecular pathogenesis has not been clearly elucidated. Here, we analyzed the roles of the LS-type SHP2 mutant Gln510Glu (Q510E), which showed the most severe type of HCM in LS, in cardiomyocyte differentiation, and in morphological changes. We generated mutant P19CL6 cell lines, the most convenient cardiomyocyte differentiation model, which continuously expressed SHP2-Q510E, SHP2-D61N (Noonan-type mutant), wild-type SHP2, and green fluorescent protein (native SHP2 expression only). SHP2-Q510E mutant P19CL6 cells showed significant attenuation of myofibrillogenesis, with increased proliferative activity. Mature cardiomyocytes from the SHP2-Q510E mutant were significantly larger than those of controls and the other mutants. However, expression of cardiac-specific transcriptional factors (Gata4, Tbx5, and Nkx2.5) did not differ significantly between the LS-type SHP2-Q510E mutants and the other mutants and controls. Our results indicate that SHP2-Q510E mutants can differentiate into cardiac progenitors but are inhibited from undergoing terminal differentiation into mature cardiomyocytes. In contrast, Akt and glycogen synthase kinase (GSK)-3β phosphorylation were upregulated, and nuclear β-catenin at the late stage of differentiation was highly accumulated in SHP2-Q510E mutant P19CL6 cells. Supplementation with the phosphoinositide 3-kinase/Akt inhibitor LY-294002 during the late stage of differentiation was found to partially restore myofibrillogenesis while suppressing the increase in size of individual mature cardiomyocytes derived from the SHP2-Q510E mutants. Our findings suggest that dysregulation of the Akt/GSK-3β/β-catenin pathway can contribute to the pathogenesis of HCM in LS patients, not only through hypertrophic changes in individual cardiac cells but also via the expansion of cardiac progenitors. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
34. A critical role for phagocytosis in resistance to malaria in iron-deficient mice.
- Author
-
Matsuzaki-Moriya, Chikako, Tu, Liping, Ishida, Hidekazu, Imai, Takashi, Suzue, Kazutomo, Hirai, Makoto, Tetsutani, Kohhei, Hamano, Shinjiro, Shimokawa, Chikako, and Hisaeda, Hajime
- Published
- 2011
- Full Text
- View/download PDF
35. Development of experimental cerebral malaria is independent of IL-23 and IL-17
- Author
-
Ishida, Hidekazu, Matsuzaki-Moriya, Chikako, Imai, Takashi, Yanagisawa, Kunio, Nojima, Yoshihisa, Suzue, Kazutomo, Hirai, Makoto, Iwakura, Yoichiro, Yoshimura, Akihiko, Hamano, Shinjiro, Shimokawa, Chikako, and Hisaeda, Hajime
- Subjects
- *
CEREBRAL malaria , *INTERLEUKINS , *IMMUNE response , *PLASMODIUM falciparum , *AUTOIMMUNITY , *INFECTION , *ERYTHROCYTES , *KILLER cells - Abstract
Abstract: Cerebral malaria (CM) is the most severe complication of Plasmodium infection. Although inappropriate immune responses to Plasmodium falciparum are reported as the major causes of CM, the precise mechanisms for development remain unclear. IL-23 and IL-17 have critical roles in the onset of autoimmunity and inflammatory diseases triggered by microbial infections. Thus, we investigated the influence of IL-23 and IL-17 on experimental CM (ECM) using Plasmodium berghei ANKA infection of C57BL/6 mice. Both IL-23 deficient mice and wild-type (WT) mice developed ECM. IL-17 deficient mice also developed ECM, while IL-17 producing cells other than CD4+ T cells (Th17) were increased in WT mice that developed ECM. In conclusion, this study showed that IL-23 and IL-17 are not involved in ECM development. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
36. Involvement of CD8.
- Author
-
Imai, Takashi, Shen, Jianying, Chou, Bin, Duan, Xuefeng, Tu, Liping, Tetsutani, Kohhei, Moriya, Chikako, Ishida, Hidekazu, Hamano, Shinjiro, Shimokawa, Chikako, Hisaeda, Hajime, and Himeno, Kunisuke
- Abstract
When developing malaria vaccines, the most crucial step is to elucidate the mechanisms involved in protective immunity against the parasites. We found that CD8 T cells contribute to protective immunity against infection with blood-stage parasites of Plasmodium yoelii. Infection of C57BL/6 mice with P. yoelii 17XL was lethal, while all mice infected with a low-virulence strain of the parasite 17XNL acquired complete resistance against re-infection with P. yoelii 17XL. However, the host mice transferred with CD8 T cells from mice primed only with P. yoelii 17XNL failed to acquire protective immunity. On the other hand, the irradiated host mice were completely resistant to P. yoelii 17XL infection, showing no grade of parasitemia when adoptively transferred with CD8 T cells from immune mice that survived infection with both P. yoelii XNL and, subsequently, P. yoelii 17XL. These protective CD8 T cells from immune WT mice had the potential to generate IFN-γ, perforin (PFN) and granzyme B. When mice deficient in IFN-γ were used as donor mice for CD8 T cells, protective immunity in the host mice was fully abrogated, and the immunity was profoundly attenuated in PFN-deficient mice. Thus, CD8 T cells producing IFN-γ and PFN appear to be involved in protective immunity against infection with blood-stage malaria. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
37. Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection.
- Author
-
Tu, Liping, Moriya, Chikako, Imai, Takashi, Ishida, Hidekazu, Tetsutani, Kohhei, Duan, Xuefeng, Murata, Shigeo, Tanaka, Keiji, Shimokawa, Chikako, Hisaeda, Hajime, and Himeno, Kunisuke
- Abstract
Proteasome-mediated proteolysis is responsible for the generation of immunogenic epitopes presented by MHC class I molecules, which activate antigen-specific CD8 T cells. Immunoproteasomes, defined by the presence of the three catalytic subunits LMP2, MECL-1, and LMP7, have been hypothesized to optimize MHC class I antigen processing. In this study, we demonstrate that the infection of mice with a protozoan parasite, Toxoplasma gondii, induced the expression of LMP7 mRNA in APC and increased the capacity of APC to induce the production of IFN-γ by antigen-specific CD8 T cells. In vitro infection of a DC cell line with T. gondii also induced the expression of LMP7 and resulted in enhanced proteasome proteolytic activity. Finally, mice lacking LMP7 were highly susceptible to infection with T. gondii and showed a reduced number of functional CD8 T cells. These results demonstrate that proteasomes containing LMP7 play an indispensable role in the survival of mice infected with T. gondii, presumably due to the efficient generation of CTL epitopes required for the functional development of CD8 T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
38. Concurrent infection with Heligmosomoides polygyrus suppresses anti- Plasmodium yoelii protection partially by induction of CD4.
- Author
-
Tetsutani, Kohhei, Ishiwata, Kenji, Ishida, Hidekazu, Tu, Liping, Torii, Motomi, Hamano, Shinjiro, Himeno, Kunisuke, and Hisaeda, Hajime
- Abstract
Malaria and intestinal nematode infection are widespread and co-infection frequently occurs. We investigated whether co-infected intestinal nematodes modulate immunity against co-existing malaria parasites. Infection of C57BL/6 mice with Plasmodium yoelii 17XNL (Py) was transient and self-limiting, but preceding infection with Heligmosomoides polygyrus (Hp), a mouse intestinal nematode, exacerbated malaria resulting in higher parasite burdens and poor survival of the mice. Co-infection with Hp led to reduced Py-responsive proliferation and IFN-γ production of spleen cells, and higher activation of CD4CD25Foxp3 Treg. In vivo depletion of Treg recovered anti-Py immunity and rescued co-infected mice from exacerbated malaria. However, we did not observe any obvious ex vivo activation of Treg by either Hp products or living worms. Our results suggest that intestinal nematodes moderate host immune responses during acute malaria infection by aggressive activation of Treg. Elucidation of the mechanisms of Treg activation in situ is a target for future analyses. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
39. Molecular cloning and partial characterization of Babesia equi EMA-3
- Author
-
Ikadai, Hiromi, Ishida, Hidekazu, Sasaki, Mizuki, Taniguchi, Keiko, Miyata, Natsumi, Koda, Maiko, Igarashi, Ikuo, and Oyamada, Takashi
- Published
- 2006
- Full Text
- View/download PDF
40. Correction: A critical role for phagocytosis in resistance to malaria in iron-deficient mice.
- Author
-
Matsuzaki-Moriya, Chikako, Tu, Liping, Ishida, Hidekazu, Imai, Takashi, Suzue, Kazutomo, Hirai, Makoto, Tetsutani, Kohhei, Hamano, Shinjiro, Shimokawa, Chikako, and Hisaeda, Hajime
- Published
- 2011
- Full Text
- View/download PDF
41. Alternatively activated macrophages determine repair of the infarcted adult murine heart.
- Author
-
Manabu Shiraishi, Yasunori Shintani, Yusuke Shintani, Hidekazu Ishida, Saba, Rie, Atsushi Yamaguchi, Hideo Adachi, Kenta Yashiro, Ken Suzuki, Shiraishi, Manabu, Shintani, Yasunori, Shintani, Yusuke, Ishida, Hidekazu, Yamaguchi, Atsushi, Adachi, Hideo, Yashiro, Kenta, and Suzuki, Ken
- Subjects
- *
MACROPHAGES , *MYOCARDIAL infarction treatment , *MURINE gammaherpesvirus diseases , *HEART rupture , *LABORATORY mice - Abstract
Alternatively activated (also known as M2) macrophages are involved in the repair of various types of organs. However, the contribution of M2 macrophages to cardiac repair after myocardial infarction (MI) remains to be fully characterized. Here, we identified CD206+F4/80+CD11b+ M2-like macrophages in the murine heart and demonstrated that this cell population predominantly increases in the infarct area and exhibits strengthened reparative abilities after MI. We evaluated mice lacking the kinase TRIB1 (Trib1-/-), which exhibit a selective depletion of M2 macrophages after MI. Compared with control animals, Trib1-/- mice had a catastrophic prognosis, with frequent cardiac rupture, as the result of markedly reduced collagen fibril formation in the infarct area due to impaired fibroblast activation. The decreased tissue repair observed in Trib1-/- mice was entirely rescued by an external supply of M2-like macrophages. Furthermore, IL-1α and osteopontin were suggested to be mediators of M2-like macrophage-induced fibroblast activation. In addition, IL-4 administration achieved a targeted increase in the number of M2-like macrophages and enhanced the post-MI prognosis of WT mice, corresponding with amplified fibroblast activation and formation of more supportive fibrous tissues in the infarcts. Together, these data demonstrate that M2-like macrophages critically determine the repair of infarcted adult murine heart by regulating fibroblast activation and suggest that IL-4 is a potential biological drug for treating MI. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
42. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2
- Author
-
Duan, Xuefeng, Yonemitsu, Yoshikazu, Chou, Bin, Yoshida, Kumi, Tanaka, Sakura, Hasegawa, Mamoru, Tetsutani, Kohhei, Ishida, Hidekazu, Himeno, Kunisuke, and Hisaeda, Hajime
- Subjects
- *
TRYPANOSOMA cruzi , *PROTOZOAN diseases , *SENDAI virus , *RECOMBINANT viruses , *GENETIC vectors , *MORTALITY , *CHAGAS' disease , *DRUG development , *PHARMACODYNAMICS , *T cells - Abstract
Abstract: Chagas’ disease, caused by infection with the protozoan parasite Trypanosoma cruzi (T. cruzi), is intractable showing a high mortality rate, and the development of effective vaccines is much desired. To examine the efficacy of a new mode of recombinant viral vaccine, we constructed two non-transmissible Sendai viruses (rSeV/dF) encoding the full-length parasite antigen amastigote surface protein-2 (ASP2) or ASP2 fused with a mono-ubiquitin on its N-terminus (UASP2). C57BL/6 mice immunized intranasally with rSeV/dF expressing either ASP2 or UASP2 showed significantly suppressed parasitemia and could be protected from lethal T. cruzi challenge. Depletion of CD8+ T cells around the time of infection with T. cruzi completely abolished this protection, confirming that acquired immunity against the infection of T. cruzi is dependent on CD8+ T cells. We also demonstrated that the protective immunity correlated with higher secretion of interferon-γ (IFN-γ) by spleen cells on in vitro-specific or non-specific stimulation. Increased CTL activity was also confirmed by degranulation or CTL assays. Interestingly, the control virus, rSeV/dF-GFP, induced even a higher IFN-γ production from spleen cells following non-specific but not specific stimulation in vitro, suggesting that SeV may also be a good adjuvant when used as a vaccine vehicle. Taking together, the current findings indicate that recombinant Sendai virus expressing the ASP2 or UASP2 antigens of T. cruzi are interesting candidates for the development of a new mode of recombinant viral vaccine against Chagas’ disease. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
43. Efficacy of thiabendazole, mebendazole, levamisole and ivermectin against gullet worm, Gongylonema pulchrum: In vitro and in vivo studies
- Author
-
Kudo, Noboru, Kubota, Hiroki, Gotoh, Hideyuki, Ishida, Hidekazu, Ikadai, Hiromi, and Oyamada, Takashi
- Subjects
- *
IMMUNOLOGICAL adjuvants , *ANTHELMINTICS , *IMIDAZOLES , *DEVELOPMENTAL biology - Abstract
Abstract: In vitro and in vivo studies were conducted to evaluate the effects of thiabendazole, mebendazole, levamisole and ivermectin against Gongylonema pulchrum. For in vitro assays, third-stage larvae (L3) incubated with the drugs were administered orally to mice and the ability of larvae to invade the gastric mucosa of the animals was examined. After incubation, only those larvae treated with high concentrations of levamisole (1 and 10μg/ml) were tightly coiled with intestines exhibiting morphological abnormalities. Good dose–response data for the drugs tested was observed at the time of worm recovery from mice, with no worms recovered at the two highest concentrations of levamisole. In vivo efficacy of the drugs against adult worms was evaluated in six groups of three rabbits, each of which was infected with 30 L3 of G. pulchrum and treated with thiabendazole at 100mg/kg for 3 days, mebendazole at 70mg/kg for 3 days, levamisole as a single dose of 8mg/kg, and subcutaneously injected ivermectin as a single dose of 0.2mg/kg or vehicles of the drugs (control) at 4 months post-infection. Necropsy 14 days after treatment revealed that levamisole, mebendazole and ivermectin reduced worm burdens by 63.2%, 22.8% and 25.8%, respectively, with no reductions in worms observed with thiabendazole. The surviving worms were principally found in the esophagus with the remainder distributed among the buccal mucosa, the tongue, and/or pharyngeal mucosa in all groups. A number of morphologically abnormal eggs were observed within the uterus and ovijector in female worms recovered from the thiabendazole-treated group. These findings suggest that levamisole exhibits in vivo efficacy against G. pulchrum infection and that the larval invasion tests using mice could be used to screen for anthelmintic susceptibility of nematodes. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
44. A chromodomain-containing nuclear protein, MRG15 is expressed as a novel type of dendritic mRNA in neurons
- Author
-
Matsuoka, Yuriko, Matsuoka, Yosuke, Shibata, Satoshi, Ban, Tadanobu, Toratani, Naomi, Shigekawa, Minoru, Ishida, Hidekazu, and Yoneda, Yoshihiro
- Subjects
- *
NEUROPLASTICITY , *DENDRITES , *MESSENGER RNA - Abstract
On the basis of a hypothesis that proteins encoded by the mRNAs that are transported to and translated at the dendrites/synapses may play key roles in synaptic plasticity, this study reports on attempts to isolate mRNAs which are localizing at the dendrites/synapses from mouse cerebellar synaptosomal fractions. Among 100 pieces of dendritic mRNA candidates, 10 pieces of mRNAs were found to contain the cytoplasmic polyadenylation element (CPE)-like sequences which were contained in certain mRNAs translated in dendrites. We next examined the issue of whether the CPE-like sequence-containing mRNAs (CPERs) were localized in the synapses/dendrites by means of in situ hybridization. The findings indicate that CPER9 was actually localized at the apical dendrites of a portion of cerebral cortex layer V pyramidal cells, as well as at the proximal dendrites of some of the cerebellar Purkinje cells. CPER9 was found to encode a mouse homolog of MRG15, a nuclear protein which contains a chromodomain identified in several proteins that act as regulators of transcription. Immunohistochemistry with anti-MRG15 antibodies revealed that MRG15 was localized in dendrites as well as in the nuclei of Purkinje cells. These results suggest that MRG15 may serve as a link between synaptic activity and gene expression. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.